GALT logo

Galectin Therapeutics (GALT) Cash From Investing

Annual CFI

$0.00
$0.000.00%

December 31, 2023

Summary

Performance

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

15-Year Change

0%

GALT Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

67.76%
GALT annual cash flow from investing activities is higher than 67.76% of companies in Healthcare sector

High & Low

All-time High

$4.95 M
GALT annual cash flow from investing activities is currently -100.00% below its historical high of $4.95 million

3-Year Low

$0.00
GALT annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GALT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
GALT next annual earnings announcement is scheduled for Mar 28, 2025

OtherGALTcash flowmetrics:

Annual CFF

$40.03 M
GALT annual cash flow from financing activities is $40.03 million

Annual CFO

-$32.97 M
GALT annual cash flow from operations is -$32.97 million

Annual FCF

-$32.97 M
GALT annual free cash flow is -$32.97 million

Annual CAPEX

-
GALT annual capital expenditures value is unknown

Quarterly CFI

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

GALT Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.97 M
GALT quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

-
GALT quarterly cash flow from investing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GALT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
GALT next earnings announcement is scheduled for Mar 28, 2025

OtherGALTcash flowmetrics:

Quarterly CFF

$10.00 M
GALT quarterly cash flow from financing activities is $10.00 million

Quarterly CFO

-$8.54 M
GALT quarterly cash flow from operations is -$8.54 million

Quarterly FCF

-$8.54 M
GALT quarterly free cash flow is -$8.54 million

Quarterly CAPEX

-
GALT quarterly capital expenditures value is unknown

TTM CFI

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

GALT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.95 M
GALT TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-
GALT TTM cash flow from investing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GALT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
GALT next earnings announcement is scheduled for Mar 28, 2025

OtherGALTcash flowmetrics:

TTM CFF

$40.38 M
GALT TTM cash flow from financing activities is $40.38 million

TTM CFO

-$33.68 M
GALT TTM cash flow from operations is -$33.68 million

TTM FCF

-$33.68 M
GALT TTM free cash flow is -$33.68 million

TTM CAPEX

-
GALT TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

GALT Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year0.0%--
3 y3 years0.0%--
5 y5 years0.0%--

GALT Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-yearat highat low
alltimeall time-100.0%+100.0%

Galectin Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2023
$0.00(0.0%)
-
-
Dec 2022
$0.00(0.0%)
-
-
Dec 2021
$0.00(0.0%)
-
-
Dec 2020
$0.00(0.0%)
-
-
Dec 2019
$0.00(0.0%)
-
-
Dec 2018
$0.00(0.0%)
-
-
Dec 2017
$0.00(0.0%)
-
-
Dec 2016
$0.00(0.0%)
-
-
Dec 2015
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2014
-$400.00 K(<-9900.0%)
$0.00(0.0%)
-$400.00 K(0.0%)
Sep 2014
-
$0.00(0.0%)
-$400.00 K(0.0%)
Jun 2014
-
$0.00(-100.0%)
-$400.00 K(0.0%)
Mar 2014
-
-$400.00 K(<-9900.0%)
-$400.00 K(<-9900.0%)
Dec 2013
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2013
-
$0.00(0.0%)
$56.00 K(-12.5%)
Jun 2013
-
$0.00(0.0%)
$64.00 K(0.0%)
Mar 2013
-
$0.00(-100.0%)
$64.00 K(0.0%)
Dec 2012
$64.00 K(-526.7%)
$56.00 K(+600.0%)
$64.00 K(+2033.3%)
Sep 2012
-
$8000.00(>+9900.0%)
$3000.00(-130.0%)
Jun 2012
-
$0.00(0.0%)
-$10.00 K(-33.3%)
Mar 2012
-
$0.00(-100.0%)
-$15.00 K(0.0%)
Dec 2011
-$15.00 K(<-9900.0%)
-$5000.00(0.0%)
-$15.00 K(+50.0%)
Sep 2011
-
-$5000.00(0.0%)
-$10.00 K(+100.0%)
Jun 2011
-
-$5000.00(<-9900.0%)
-$5000.00(<-9900.0%)
Mar 2011
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2010
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2010
-
$0.00
$0.00
DateAnnualQuarterlyTTM
Dec 2009
$0.00(-100.0%)
-
-
Dec 2008
$9000.00(-99.8%)
$3000.00(-40.0%)
$9000.00(-77.5%)
Sep 2008
-
$5000.00(>+9900.0%)
$40.00 K(+17.6%)
Jun 2008
-
$0.00(-100.0%)
$34.00 K(-261.9%)
Mar 2008
-
$1000.00(-97.1%)
-$21.00 K(-100.4%)
Dec 2007
$4.95 M(-194.5%)
$34.00 K(-3500.0%)
$4.95 M(+2.2%)
Sep 2007
-
-$1000.00(-98.2%)
$4.84 M(+1.7%)
Jun 2007
-
-$55.00 K(-101.1%)
$4.76 M(-1997.2%)
Mar 2007
-
$4.97 M(-7098.6%)
-$251.00 K(-95.2%)
Dec 2006
-$5.24 M(+4617.1%)
-$71.00 K(-12.3%)
-$5.24 M(+1.6%)
Sep 2006
-
-$81.00 K(-98.4%)
-$5.16 M(+0.9%)
Jun 2006
-
-$5.07 M(>+9900.0%)
-$5.11 M(+5451.1%)
Mar 2006
-
-$16.00 K(-260.0%)
-$92.00 K(-17.1%)
Dec 2005
-$111.00 K(+60.9%)
$10.00 K(-130.3%)
-$111.00 K(-11.9%)
Sep 2005
-
-$33.00 K(-37.7%)
-$126.00 K(+2.4%)
Jun 2005
-
-$53.00 K(+51.4%)
-$123.00 K(+60.4%)
Mar 2005
-
-$35.00 K(+600.0%)
-$76.70 K(+11.2%)
Dec 2004
-$69.00 K(-34.3%)
-$5000.00(-83.3%)
-$69.00 K(-15.3%)
Sep 2004
-
-$30.00 K(+347.8%)
-$81.50 K(+19.3%)
Jun 2004
-
-$6700.00(-75.5%)
-$68.30 K(-21.8%)
Mar 2004
-
-$27.30 K(+56.0%)
-$87.30 K(-16.9%)
Dec 2003
-$105.00 K(-24.1%)
-$17.50 K(+4.2%)
-$105.00 K(-13.2%)
Sep 2003
-
-$16.80 K(-34.6%)
-$121.00 K(+11.2%)
Jun 2003
-
-$25.70 K(-42.9%)
-$108.80 K(-19.6%)
Mar 2003
-
-$45.00 K(+34.3%)
-$135.40 K(-2.1%)
Dec 2002
-$138.30 K(-19.2%)
-$33.50 K(+628.3%)
-$138.30 K(+32.0%)
Sep 2002
-
-$4600.00(-91.2%)
-$104.80 K(+4.6%)
Jun 2002
-
-$52.30 K(+9.2%)
-$100.20 K(+109.2%)
Mar 2002
-
-$47.90 K
-$47.90 K
Dec 2001
-$171.10 K
-
-

FAQ

  • What is Galectin Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Galectin Therapeutics?
  • What is Galectin Therapeutics annual CFI year-on-year change?
  • What is the all time high quarterly CFI for Galectin Therapeutics?
  • What is the all time high TTM CFI for Galectin Therapeutics?

What is Galectin Therapeutics annual cash flow from investing activities?

The current annual CFI of GALT is $0.00

What is the all time high annual CFI for Galectin Therapeutics?

Galectin Therapeutics all-time high annual cash flow from investing activities is $4.95 M

What is Galectin Therapeutics annual CFI year-on-year change?

Over the past year, GALT annual cash flow from investing activities has changed by $0.00 (0.00%)

What is the all time high quarterly CFI for Galectin Therapeutics?

Galectin Therapeutics all-time high quarterly cash flow from investing activities is $4.97 M

What is the all time high TTM CFI for Galectin Therapeutics?

Galectin Therapeutics all-time high TTM cash flow from investing activities is $4.95 M